TNG Stock Overview
Manufactures and sells Chinese medicine products in Mainland China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.61 |
| 52 Week High | HK$0.78 |
| 52 Week Low | HK$0.53 |
| Beta | 1.05 |
| 11 Month Change | -2.38% |
| 3 Month Change | 6.96% |
| 1 Year Change | -20.65% |
| 33 Year Change | -8.89% |
| 5 Year Change | -20.13% |
| Change since IPO | -50.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| TNG | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -3.9% | 1.6% | 1.1% |
| 1Y | -20.6% | -19.0% | 7.2% |
Return vs Industry: TNG underperformed the German Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: TNG underperformed the German Market which returned 7.2% over the past year.
Price Volatility
| TNG volatility | |
|---|---|
| TNG Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TNG's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: TNG's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 4,005 | Jia Fu Chen | www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
| TNG fundamental statistics | |
|---|---|
| Market cap | €792.39m |
| Earnings (TTM) | €85.12m |
| Revenue (TTM) | €899.53m |
9.3x
P/E Ratio0.9x
P/S RatioIs TNG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TNG income statement (TTM) | |
|---|---|
| Revenue | CN¥6.88b |
| Cost of Revenue | CN¥4.06b |
| Gross Profit | CN¥2.82b |
| Other Expenses | CN¥2.17b |
| Earnings | CN¥650.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 40.97% |
| Net Profit Margin | 9.46% |
| Debt/Equity Ratio | 22.7% |
How did TNG perform over the long term?
See historical performance and comparison